Shanghai Fosun Pharmaceutical Group has agreed to cut the size of the stake it would buy in Hyderabad-based injectable maker Gland Pharma to 74 percent in a revised $1.09-billion (around Rs 6,900 cr) deal after its...
Teva to sell contraceptive brand Paragard in $1.1 billion deal
Teva Pharmaceutical Industries (TEVA.TA), (TEVA.N) on Monday agreed to sell its contraceptive brand Paragard to a unit of Cooper Cos (COO.N) for $1.1 billion, on a day the struggling Israeli drugmaker named industry...
Mylan looks to sell off Vizag formulations unit it acquired in 2012
American generics drug major Mylan is looking for a buyer for its formulations manufacturing facility in Vizag Pharma City. While there was no official confirmation either on the decision or the reasons behind it from...
Merck KGaA may sell consumer health business
Merck KGaA is looking to sell its $1-billion global consumer health business, including that in India, in a move that the German drugmaker said will be an important step in executing its science and technology-focused...
Baring PE Asia eyes stake in Symbiotec Pharmalab
Private equity fund Baring PE Asia is in talks to buy a controlling stake in Actis Capital-backed steroid maker Symbiotec Pharmalab Ltd, two people familiar with the development said. PE fund Actis now holds a 70% stake...
Japan’s Daiichi Sankyo denies 2016 takeover bid by AstraZeneca
Japanese drugmaker Daiichi Sankyo denied on Thursday it received a takeover bid last year from Britain’s AstraZeneca, following speculation that sent its share price soaring as much as 13 percent and triggered a trade...
Strides Shasun arm acquires Australian operations of Amneal Pharma
Drug firm Strides Shasun on Thursday said its arm Arrow Pharmaceuticals has acquired Australian operations of Amneal Pharmaceuticals for a total consideration of Australian dollar (AUD) 17 million (over Rs85 crore). The...
Aurobindo Pharma in talks to buy Shreya Life Sciences’s Russia business
Aurobindo Pharma Ltd is in talks to buy the Russia business of Mumbai-based Shreya Life Sciences Pvt. Ltd in a deal potentially valued between $80 million and $100 million, two people aware of the discussions said on...
Gilead to buy Kite Pharma for promising cancer therapies in $12 billion deal
Gilead Sciences Inc. agreed to buy Kite Pharma Inc. in a nearly $12 billion deal on Monday, as it looks to replace flagging sales from hepatitis C drugs with an emerging and expensive class of cancer immunotherapies...
Alembic Pharma sells Baddi facility to Scott Edil for undisclosed amount
Vadodara-based pharmaceutical major Alembic Pharma sold off its non-core asset, the Baddi manufacturing facility, on a slump-sale basis for an undisclosed sum to Chandigarh-headquartered pharma firm Scot Edil Pharmacia...
NCLT initiates insolvency proceedings against Orchid Pharma
The National Company Law Tribunal (NCLT) has issued an order to appoint an interim resolution professional (IRP) to take charge of the management of the Chennai-based listed pharmaceutical firm Orchid Pharma Ltd. The...
Cadila Healthcare, Torrent Pharma eyeing potential merger
The domestic pharmaceuticals sector may be set for a shake-up as Ahmedabad headquartered Cadila HealthcareBSE -0.22 % led by Pankaj Patel and the Mehta family backed Torrent Pharmaceuticals are re-evaluating a potential...
